Integrative AI and Molecular Simulation Reveal Andrograpanin as a Potent Dual Inhibitor of EYA1 and TFAP2A in Triple-Negative Breast Cancer
Crossref DOI link: https://doi.org/10.1007/s12247-026-10731-7
Published Online: 2026-05-11
Published Print: 2026-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Skariyachan, Sinosh
Nair, Aryalakshmi Gangadharan Sreenilayam
Sebastian, Denoj
K, Sreejith
Text and Data Mining valid from 2026-05-11
Version of Record valid from 2026-05-11
Article History
Received: 23 November 2025
Accepted: 3 May 2026
First Online: 11 May 2026
Declarations
:
: The authors declare no competing interests.